Association between glutathione S-transferase A1, M1 and T1 polymorphisms and hypertension

Pharmacogenetics and Genomics

Volumn 18, Issue 3, 2008, Pages 275-277

  Oniki, Kentaro ^a   Hori, Masaharu ^a   Takata, Keiji ^a   Yokoyama, Tomoko ^a   Mihara, Shuichi ^b   Marubayashi, Toru ^b   Nakagawa, Kazuko ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

Author keywords

Genetic polymorphism; Genetic risk factor; Glutathione S transferase; GSTA1; GSTM1; GSTT1; Hypertension

Indexed keywords

GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NULL ALLELE; PRIORITY JOURNAL; RISK;

ADULT; AGED; ALLELES; FEMALE; GENE FREQUENCY; GLUTATHIONE TRANSFERASE; HUMANS; HYPERTENSION; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; PHARMACOGENETICS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 40049107137     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3282f56176     Document Type: Article

References (10)

1. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004; 44:248-252.
2. Johnson RJ, Rodriguez-Iturbe B, Kang DH, Feig DI, Herrera-Acosta J. A unifying pathway for essential hypertension. Am J Hypertens 2005; 18:431-440.
3. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45:51-88.
4. Coles BF, Kadlubar FF. Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol 2005; 401:9-42.
5. Coles BF, Morel F, Rauch C, Huber WW, Yang M, Teitel CH, et al. Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 2001; 11:663-669.
6. Ping J, Wang H, Huang M, Liu ZS. Genetic analysis of glutathione S-transferase A1 polymorphism in the Chinese population and the influence of genotype on enzymatic properties. Toxicol Sci 2006; 89:438-443.
7. Ueda K, Ishitsu T, Seo T, Ueda N, Murata T, Hori M, et al. Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity. Pharmacogenomics 2007; 8:435-442.
8. Yang Y, Yang Y, Trent MB, He N, Lick SD, Zimniak P, et al. Glutathione-S-transferase A4-4 modulates oxidative stress in endothelium: possible role in human atherosclerosis. Atherosclerosis 2004; 173:211-221.
9. Korashy HM, El-Kadi AO. The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases. Drug Metab Rev 2006; 38:411-450.
10. Marinho C, Alho I, Arduino D, Falcao LM, Bras-Nogueira J, Bicho M. GST M1/T1 and MTHFR polymorphisms as risk factors for hypertension. Biochem Biophys Res Commun 2007; 353:344-350.